Table 2.

Multivariable logistic regression models demonstrating the odds ratio in patients with cancer compared to the general population who had received a third dose booster.

Age,	Breakthrough infections	p	Symptomatic infections	p	Hospitalisation	p	Death	p
All ages	0.99 (0.96–1.03)	0.77	0.73 (0.70–0.76)	<0.00001	3.38 (3.03–3.77)	<0.00001	3.01 (2.48–3.65)	<0.00001
18–39	1.37 (1.09–1.71)	0.0064	0.73 (0.55–0.98)	0.033	11.50 (5.67–23.34)	<0.00001	67.15 (5.05–893.14)	0.0014
40–59	1.06 (0.98–1.15)	0.15	0.66 (0.60–0.73)	<0.00001	5.71 (4.36–7.48)	<0.00001	10.77 (5.66–20.51)	<0.00001
60–79	0.94 (0.89–0.99)	0.013	0.76 (0.72–0.81)	<0.00001	3.17 (2.75–3.66)	<0.00001	3.07 (2.33–4.05)	<0.00001
80+	1.10 (1.00–1.21)	0.043	0.93 (0.83–1.03)	0.16	1.49 (1.19–1.87)	0.00057	1.53 (1.12–2.09)	0.0073